Cargando…

Editorial Commentary: Single-Dose Primaquine as Gametocytocidal Treatment in Patients With Uncomplicated Falciparum Malaria

Detalles Bibliográficos
Autor principal:	Dondorp, Arjen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563393/ https://www.ncbi.nlm.nih.gov/pubmed/23175557 http://dx.doi.org/10.1093/cid/cis962

Ejemplares similares

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
por: Pett, Helmi, et al.
Publicado: (2019)

Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
por: Stepniewska, Kasia, et al.
Publicado: (2022)

Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria
por: White, Nicholas J, et al.
Publicado: (2014)

An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa
por: Chen, Ingrid, et al.
Publicado: (2015)

Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022)

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
por: Mukaka, Mavuto, et al.
Publicado: (2023)

A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
por: Gogtay, NJ, et al.
Publicado: (2006)

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
por: White, Nicholas J, et al.
Publicado: (2012)

Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania
por: Mwaiswelo, Richard, et al.
Publicado: (2016)

The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial()
por: Okebe, Joseph, et al.
Publicado: (2016)

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
por: Onyamboko, Marie A., et al.
Publicado: (2023)

Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations
por: Lubell, Yoel, et al.
Publicado: (2014)

The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial
por: Okebe, Joseph, et al.
Publicado: (2015)

Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial
por: Tine, Roger C., et al.
Publicado: (2017)

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial
por: Smithuis, Frank, et al.
Publicado: (2010)

Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance
por: Maude, Richard J., et al.
Publicado: (2012)

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials
por: Kiszewski, Anthony E.
Publicado: (2010)

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Artesunate Dosing in Severe Falciparum Malaria
por: Dondorp, Arjen M., et al.
Publicado: (2012)

Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014)

Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda
por: Eziefula, Alice Chijioke, et al.
Publicado: (2013)

Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria
por: Vantaux, Amélie, et al.
Publicado: (2020)

Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial
por: Mwaiswelo, Richard, et al.
Publicado: (2016)

Streamlined and Robust Stage-Specific Profiling of Gametocytocidal Compounds Against Plasmodium falciparum
por: Reader, Janette, et al.
Publicado: (2022)

Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial
por: Coulibaly, Boubacar, et al.
Publicado: (2009)

Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk
por: John, Chandy C.
Publicado: (2016)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity
por: Sanders, Natalie G., et al.
Publicado: (2014)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
por: Taylor, Walter Robert, et al.
Publicado: (2021)

The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin–piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos
por: Pongvongsa, Tiengkham, et al.
Publicado: (2018)

A Randomized Comparison of Dihydroartemisinin-Piperaquine and Artesunate-Amodiaquine Combined With Primaquine for Radical Treatment of Vivax Malaria in Sumatera, Indonesia
por: Pasaribu, Ayodhia Pitaloka, et al.
Publicado: (2013)

Liver injury in uncomplicated malaria: an overlooked phenomenon
por: Moore, Brioni R.
Publicado: (2018)

Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
por: Raobela, Oméga, et al.
Publicado: (2018)

WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria
por: Peto, Thomas J, et al.
Publicado: (2023)

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
por: Dysoley, Lek, et al.
Publicado: (2019)

Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria
por: Plewes, Katherine, et al.
Publicado: (2018)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area
por: Wångdahl, Andreas, et al.
Publicado: (2021)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pe2q4868igl17u3iqdjiup49fm